Aflibercept biosimilar use and real-world outcomes in various retinal diseases: the AURA Korea study.

Song JR, Jeon J, Baek SC, Sharma A, Sagong M, Lee CS, Woo SJ, International Retina Biosimilar Study Group (Inter BIOS Group)

Open source

DOI
10.1038/s41598-026-52212-4
Published
2026 Jun 12
Container
Scientific reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-026-52212-4,
  title = {Aflibercept biosimilar use and real-world outcomes in various retinal diseases: the AURA Korea study.},
  author = {Song JR and Jeon J and Baek SC and Sharma A and Sagong M and Lee CS and Woo SJ and International Retina Biosimilar Study Group (Inter BIOS Group)},
  year = {2026},
  journal = {Scientific reports},
  doi = {10.1038/s41598-026-52212-4},
  url = {https://doi.org/10.1038/s41598-026-52212-4}
}

RIS

TY  - JOUR
TI  - Aflibercept biosimilar use and real-world outcomes in various retinal diseases: the AURA Korea study.
AU  - Song JR
AU  - Jeon J
AU  - Baek SC
AU  - Sharma A
AU  - Sagong M
AU  - Lee CS
AU  - Woo SJ
AU  - International Retina Biosimilar Study Group (Inter BIOS Group)
PY  - 2026
JO  - Scientific reports
DO  - 10.1038/s41598-026-52212-4
UR  - https://doi.org/10.1038/s41598-026-52212-4
ER  - 

APA

JR, S., J, J., SC, B., A, S., M, S., CS, L., SJ, W., & Group), I. R. B. S. G. (. B. (2026). Aflibercept biosimilar use and real-world outcomes in various retinal diseases: the AURA Korea study.. Scientific reports. https://doi.org/10.1038/s41598-026-52212-4

Source records